#ITI#Efficacy of an inactivated and a fowlpox-vectored vaccine in muscovy ducks against an Asian H5N1 highly pathogenic avian influenza viral challenge#FTI#
#IRE#The efficacy of an inactivated vaccine containing the Eurasian isolate A/chicken/Italy/22A/98 H5N9 (H5N9-It) was compared with that of the fowlpox-vectored TROVACâ„¢-AIV H5 (rFP-AIV-H5) vaccine against an H5N1 highly pathogenic avian influenza challenge. Five-week-old Muscovy ducks were vaccinated with either H5N9-It (0.5 ml) or rFP-AIV-H5 (5 log10 50% tissue culture infectious dose (TCID50)/dose), followed by a boost at 7 wk of age with the same vaccine (1.0 ml of H5N9-It or 5 log10 TCID50/dose rFP-AIV-H5), and a challenge at 9 wk of age with 10 7 egg infectious dose (lethality 50%) of A/crested eagle/ Belgium/01/2004 (H5N1). All unvaccinated challenged birds showed severe nervous signs (loss of balance, torticollis) starting 7 days postinfection (dpi). None of the vaccinated ducks showed these nervous signs. Shedding was measured in oropharyngeal and cloacal swabs, sampled from 3 to 19 dpi by titration in chicken embryo fibroblasts and by real-time reverse transcription-polymerase chain reaction. Virus shedding was significantly higher in oropharyngeal compared to cloacal swabs. Both vaccines reduced the percentage of positive swabs and the viral load in the swabs, but the reduction was higher with the H5N9-It vaccine. The inactivated vaccine induced hemagglutination inhibition (HI) titers (5.4 log2) that were boosted after the second administration (7.5 log2). rFP-AIV-H5-induced HI titers were lower (3 log2 only after the second administration), most probably because the fowlpox vector does not replicate in ducks. Altogether, these results indicate that significant protection from clinical signs and reduction in virus shedding may be achieved in ducks with conventional inactivated or fowlpox-vectored vaccine as compared with nonvaccinated challenged control birds.#FRE#
#IPC#Avian influenza; Duck; H5N1; Inactivated whole virus vaccine; Recombinant fowlpox vaccine; Vaccination#FPC#
#IRF#Alexander D.J., Parsons G., Manvell R.J., Experimental assessment of the pathogenicity of eight influenza A viruses of H5 subtype for chickens, turkeys and quail, Avian Pathol, 15, pp. 647-662, (1986); 
Beard C.W., Schnitzlein W.M., Tripathy D.N., Protection of chickens against highly pathogenic avian influenza virus (H5N2) by recombinant fowlpox viruses, Avian Dis, 35, pp. 356-359, (1991); 
Brugh M., Beard C.W., Stone H.D., Immunization of chickens and turkeys against avian influenza with monovalent and polyvalent oil emulsion vaccines, Am. J. Vet. Res, 40, pp. 165-169, (1979); 
Bublot M., Pritchard N., Cruz J., Mickle T.R., Selleck P., Swayne D.E., Efficacy of a recombinant fowl poxvirus-avian influenza H5 vaccine against Asian H5N1 highly pathogenic avian influenza virus challenge, Avian Dis, 51, SUPPL., pp. 498-500, (2007); 
Bublot M., Swayne D.E., Selleck P., Montiel E., Pritchard N., Lee M., TROVAC AI H5, an avian influenza fowlpox vector vaccine, as an alternative vaccine for hatcheries, OIE/FAO International Scientific Conference on Avian Influenza, April 7-8, 2005, Paris. 124:248, (2005); 
Capua I., Cattoli G., Marangon S., DIVA-a vaccination strategy enabling the detection of field exposure to avian influenza, Dev. Biol. (Basel), 119, pp. 229-233, (2004); 
Capua I., Terregino C., Cattoli G., Mutinelli F., Rodriguez J.F., Development of a DIVA (differentiating infected from vaccinated animals) strategy using a vaccine containing a heterologous neuraminidase for the control of avian influenza, Avian Pathol, 32, pp. 47-55, (2003); 
Council Directive 92/40/EEC of 19 May 1992 introducing Community measures for the control of avian influenza, Official Journal of the European Communities, L167, pp. 1-16, (1992); 
Elbers A.R., Koch G., Bouma A., Performance of clinical signs in poultry for the detection of outbreaks during the avian influenza A (H7N7) epidemic in the Netherlands in 2003, Avian Pathol, 34, pp. 181-187, (2005); 
Ellis T.M., Leung C.Y., Chow M.K., Bissett L.A., Wong W., Guan Y., Malik Peiris J.S., Vaccination of chickens against H5N1 avian influenza in the face of an outbreak interrupts virus transmission, Avian Pathol, 33, pp. 405-412, (2004); 
Ellis T.M., Sims L.D., Wong H.K.W., Bissett L.A., Dyrting K.C., Chow K.W., Wong C.W., Evaluation of vaccination to support control of H5N1 avian influenza in Hong Kong, Wageningen UR Frontis Series: Avian influenza, prevention and control, pp. 75-84, (2004); 
Fouchier R.A., Olsen B., Bestebroer T.M., Herfst S., van der Kemp L., Rimmelzwaan G.F., Osterhaus A.D., Influenza A virus surveillance in wild birds in Northern Europe in 1999 and 2000, Avian Dis, 47, pp. 857-860, (2003); 
Hatchette T.F., Walker D., Johnson C., Baker A., Pryor S.P., Webster R.G., Influenza A viruses in feral Canadian ducks: Extensive reassortment in nature, J. Gen. Virol, 85, pp. 2327-2337, (2004); 
Hirst G.K., The quantitative determination of influenza virus and antibodies by mean of red cell agglutination, J. Exp. Med, 75, pp. 49-64, (1942); 
Karaca K., Swayne D.E., Grosenbaugh D., Bublot M., Robles A., Spackman E., Nordgren R., Immunogenicity of fowlpox virus expressing the avian influenza virus H5 gene (TROVAC AIV-H5) in cats, Clin. Diagn. Lab. Immunol, 12, pp. 1340-1342, (2005); 
Munster V.J., Wallensten A., Baas C., Rimmelzwaan G.F., Schutten M., Olsen B., Osterhaus A.D., Fouchier R.A., Mallards and highly pathogenic avian influenza ancestral viruses, northern Europe, Emerg. Infect. Dis, 11, pp. 1545-1551, (2005); 
A global strategy for the progressive control of highly pathogenic avian influenza (HPAI), (2005); 
Paillot R., Hannant D., Kydd J.H., Daly J.M., Vaccination against equine influenza: Quid novi?, Vaccine, 24, pp. 4047-4061, (2006); 
Paoletti E., Applications of pox virus vectors to vaccination: An update, Proc. Natl. Acad. Sci. U. S. A, 93, pp. 11349-11353, (1996); 
Paoletti E., Taylor J., Meignier B., Meric C., Tartaglia J., Highly attenuated poxvirus vectors: NYVAC, ALVAC and TROVAC, Dev. Biol. Stand, 84, pp. 159-163, (1995); 
Perkins L.E., Swayne D.E., Pathogenicity of a Hong Kong-origin H5N1 highly pathogenic avian influenza virus for emus, geese, ducks, and pigeons, Avian Dis, 46, pp. 53-63, (2002); 
Qiao C.L., Yu K.Z., Jiang Y.P., Jia Y.Q., Tian G.B., Liu M., Deng G.H., Wang X.R., Meng Q.W., Tang X.Y., Protection of chickens against highly lethal H5N1 and H7N1 avian influenza viruses with a recombinant fowlpox virus co-expressing H5 haemagglutinin and N1 neuraminidase genes, Avian Pathol, 32, pp. 25-32, (2003); 
Qiao C., Yu K., Jiang Y., Li C., Tian G., Wang X., Chen H., Development of a recombinant fowlpox virus vector-based vaccine of H5N1 subtype avian influenza, Dev. Biol. (Basel), 124, pp. 127-132, (2006); 
Reed L.J., Muench H., A simple method for estimating fifty endpoints, Am. J. Hyg, 27, pp. 493-497, (1938); 
Slemons R.D., Hansen W.R., Converse K.A., Senne D.A., Type A influenza virus surveillance in free-flying, nonmigratory ducks residing on the eastern shore of Maryland, Avian Dis, 47, pp. 1107-1110, (2003); 
Spackman E., Senne D.A., Myers T.J., Bulaga L.L., Garber L.P., Perdue M.L., Lohman K., Daum L.T., Suarez D.L., Development of a real-time reverse transcriptase PCR assay for type A influenza virus and the avian H5 and H7 hemagglutinin subtypes, J. Clin. Microbiol, 40, pp. 3256-3260, (2002); 
Steensels M., Van Borm S., Boschmans M., van den Berg T., Lethality and molecular characterisation of an HPAI H5N1 virus isolated from eagles smuggled from Thailand into Europe, Avian Dis, 51, SUPPL., pp. 401-407, (2007); 
Sturm-Ramirez K.M., Ellis T., Bousfield B., Bissett L., Dyrting K., Rehg J.E., Poon L., Guan Y., Peiris M., Webster R.G., Reemerging H5N1 influenza viruses in Hong Kong in 2002 are highly pathogenic to ducks, J. Virol, 78, pp. 4892-48901, (2004); 
Sturm-Ramirez K.M., Hulse-Post D.J., Govorkova E.A., Humberd J., Seiler P., Puthavathana P., Buranathai C., Nguyen T.D., Chaisingh A., Long H.T., Naipospos T.S., Chen H., Ellis T.M., Guan Y., Peiris J.S., Webster R.G., Are ducks contributing to the endemicity of highly pathogenic H5N1 influenza virus in Asia?, J. Virol, 79, pp. 11269-11279, (2005); 
Suarez D.L., Overview of avian influenza DIVA test strategies, Biologicals, 33, pp. 221-226, (2005); 
Suarez D.L., Schultz-Cherry S., Immunology of avian influenza virus: A review, Dev. Comp. Immunol, 24, pp. 269-283, (2000); 
Swayne D.E., Application of new vaccine technologies for the control of transboundary diseases, Dev. Biol. (Basel), 119, pp. 219-228, (2004); 
Swayne D.E., Beck J.R., Mickle T.R., Efficacy of recombinant fowl poxvirus vaccine in protecting chickens against a highly pathogenic Mexican-origin H5N2 avian influenza virus, Avian Dis, 41, pp. 910-922, (1997); 
Swayne D.E., Beck J.R., Perdue M.L., Beard C.W., Efficacy of vaccines in chickens against highly pathogenic Hong Kong H5N1 avian influenza, Avian Dis, 45, pp. 355-365, (2001); 
Swayne D.E., Garcia M., Beck J.R., Kinney N., Suarez D.L., Protection against diverse highly pathogenic H5 avian influenza viruses in chickens immunized with a recombinant fowlpox vaccine containing an H5 avian influenza hemagglutinin gene insert, Vaccine, 18, pp. 1088-1095, (2000); 
Swayne D.E., Glisson J.R., Jackwood M.W., Pearson J.E., Reed M.W., A laboratory manual for the isolation and identification of avian pathogens, pp. 150-155, (1998); 
Swayne D.E., Pantin-Jackwood M., Pathogenicity of avian influenza viruses in poultry, Dev. Biol. (Basel), 124, pp. 61-67, (2006); 
Swayne D.E., Perdue M.L., Beck J.R., Garcia M., Suarez D.L., Vaccines protect chickens against H5 highly pathogenic avian influenza in the face of genetic changes in field viruses over multiple years, Vet. Microbiol, 74, pp. 165-172, (2000); 
Swayne D.E., Suarez D.L., Highly pathogenic avian influenza, Rev. Sci. Tech, 19, pp. 463-482, (2000); 
Tian G., Zhang S., Li Y., Bu Z., Liu P., Zhou J., Li C., Shi J., Yu K., Chen H., Protective efficacy in chickens, geese and ducks of an H5N1-inactivated vaccine developed by reverse genetics, Virology, 341, pp. 153-162, (2005); 
Van Borm S., Steensels M., Ferreira H.L., Boschmans M., De Vriese J., Lambrecht B., van den Berg T., A universal avian endogenous real time RT-PCR control and its application to avian influenza diagnosis and quantification, Avian Dis, 51, SUPPL., pp. 213-220, (2007); 
Van Borm S., Thomas I., Hanquet G., Lambrecht B., Boschmans M., Dupont G., Decaestecker M., Snacken R., van den Berg T., Highly pathogenic H5N1 influenza virus in smuggled Thai eagles, Belgium, Emerg Infect Dis, 11, pp. 702-705, (2005); 
Webster R., Hulse D., Controlling avian flu at the source, Nature, 435, pp. 415-416, (2005); 
Webster R.G., Bean W.J., Gorman O.T., Chambers T.M., Kawaoka Y., Evolution and ecology of influenza A viruses, Microbiol Rev, 56, pp. 152-179, (1992); 
Webster R.G., Taylor J., Pearson J., Rivera E., Paoletti E., Immunity to Mexican H5N2 avian influenza viruses induced by a fowl pox-H5 recombinant, Avian Dis, 40, pp. 461-465, (1996); 
Webster R.G., Webby R.J., Hoffmann E., Rodenberg J., Kumar M., Chu H.J., Seiler P., Krauss S., Songserm T., The immunogenicity and efficacy against H5N1 challenge of reverse genetics-derived H5N3 influenza vaccine in ducks and chickens, Virology, 351, pp. 303-311, (2006); 
Woodland D.L., Jump-starting the immune system: Prime-boosting comes of age, Trends Immunol, 25, pp. 98-104, (2004)#FRF#
